Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art


app icon


app store icon


Orthopedic and Dental Industry News Complete Archive »

Alphatec Spine Announces Executive Leadership Changes BY EDITOR, JANUARY 2, 2014

Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, announced that Mike Plunkett will succeed Pat Ryan as Chief Operating Officer. Mr. Ryan, who has led Alphatec Spine's global operations since 2011, has announced his intention to resign from the company to pursue other opportunities.

Mr. Plunkett joined Alphatec Spine in 2012 as Vice President Operations, where he was responsible for U.S. operations, including supply chain, production, manufacturing engineering, facilities and information technology. In his new role, Mr. Plunkett will have responsibility for global supply chain, clinical, regulatory, quality and research and development, as well as continuing to lead and deliver improvements in global operations. In addition, he will be focused on delivering Alphatec's next-generation pedicle screw system to the market and ensuring that there is a continuous flow of new products. Mr. Plunkett brings over 30 years of proven results and experience leading complex supply chain operations, manufacturing and program management, including serving over 24 years in the U.S. Navy, retiring with the rank of Captain in 2003. "During the last eighteen months Mike has been responsible for driving many improvements in our U.S. operations, including driving Lean Enterprise throughout the supply chain and manufacturing functions," said Les Cross, Chairman and CEO. "Mike's appointment to this role demonstrates the bench strength of our management team," continued Mr. Cross. "We are placing a proven and respected executive in a key position as we continue to pursue our strategic objectives to deliver shareholder value and help improve the lives of the patients we serve across the globe."

Mr. Plunkett will report to Mr. Cross and will begin transitioning into his new role immediately.

Pat Ryan has announced his resignation, but will stay with the Company until mid-January to transition his responsibilities.

Mr. Cross added, "Pat has delivered strong results during his time at the Company and we are grateful for the many contributions he has made, including building a team and a culture that have proven to be successful in our ongoing Company operations. We wish him all the best in his future endeavors. I am confident that Mike Plunkett will build further on the foundation Pat has established."

In addition, Mike O'Neill, Chief Financial Officer, will assume responsibility for international commercial operations.

Mr. O'Neill joined the Company in 2010 and brings more than 30 years of experience in international businesses, including over 20 years at Johnson & Johnson. "Mike possesses a deep understanding of our international markets and customers, having dealt closely with the global commercial team over the last three years, which made him a natural choice to lead our international commercial operations," said Mr. Cross.

Email this to a colleague: